National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-thymocyte globulin
A purified gamma immunoglobulin (IgG) with immunosuppressive activity. Obtained from rabbits that have been immunized with human thymocytes, antithymocyte globulin specifically recognizes and destroys T lymphocytes. Although the exact mechanism of action is not completely understood, it appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering antithymocyte globulin with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host disease. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:lymphocyte immune globulin
US brand names:ATGAM
Thymoglobulin
Abbreviation:ATG



Previous:anti-IL-6 chimeric monoclonal antibody, anti-p53 T-cell receptor-transduced peripheral blood lymphocytes, anti-PD-1 human monoclonal antibody MDX-1106, anti-PD-1 monoclonal antibody CT-011, anti-PSCA fully human monoclonal antibody MK4721
Next:anti-TRAIL receptor 2 monoclonal antibody AMG 655, Anti-VEGFR-2 fully human monoclonal antibody IMC-1121B, antineoplaston A10, antineoplaston AS2-1, Antrin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov